Abstract Representational biases that are common in biological data can inflate prediction performance and confound our understanding of how and what machine learning (ML) models learn from large complicated datasets. However, auditing for these biases is not a common practice in ML in the life sciences. Here, we devise a systematic auditing framework and harness it to audit three different ML applications of significant therapeutic interest: prediction frameworks of protein-protein interactions, drug-target bioactivity, and MHC-peptide binding. Through this, we identify unrecognized biases that hinder the ML process and result in low model generalizability. Ultimately, we show that, when there is insufficient signal in the training data, ML models are likely to learn primarily from representational biases.

Systematic auditing is essential to debiasing machine learning in biology